Loading…
Based on limited metadata without access to the full warning letter text, this FDA Warning Letter issued to Olympus Medical Systems Corp. on March 15, 2023, concerns medical devices manufactured or distributed by the company. The specific nature of the regulatory violations cannot be determined from the available metadata, as no subject line or detailed information has been provided. The warning falls under FDA's medical device regulatory authority, though the specific issuing office and violation count are not available in this summary. To understand the precise compliance issues and required corrective actions, the complete warning letter would need to be reviewed.